Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Nature Communications|March 21, 2025
Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphositesWen Jiang, Eric J Jaehnig, Yuxing Liao, et al.
Cold Spring Harbor Perspectives in Medicine|May 3, 2023
The Breast Cancer Proteome and Precision OncologyJonathan T Lei, Eric J Jaehnig, Hannah Smith, et al.
Molecular and Cellular Biology|April 15, 2004
HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivoJoshua P Anderson, Evdokia Dodou, Analeah B Heidt, et al.
Development (Cambridge, England)|January 27, 2016
MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1Ralston M Barnes, Ian S Harris, Eric J Jaehnig, et al.
Clinical Proteomics|January 15, 2024
Kinase inhibitor pulldown assay (KiP) for clinical proteomicsAlexander B Saltzman, Doug W Chan, Matthew V Holt, et al.
Cancer Research Communications|August 17, 2023
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding ProteinsJunkai Wang, Alexander B Saltzman, Eric J Jaehnig, et al.
JCI Insight|June 2, 2017
Identification and characterization of a supraclavicular brown adipose tissue in miceQianxing Mo, Jordan Salley, Tony Roshan, et al.
Cell|June 25, 2024
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSara R Savage, Xinpei Yi, Jonathan T Lei, et al.
Oncotarget|October 6, 2015
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibitionJohn Paul Shen, Rohith Srivas, Andrew Gross, et al.
Nature Communications|May 22, 2025
Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Pageof 4